Napolitano, F.; Formisano, L.; Giardino, A.; Girelli, R.; Servetto, A.; Santaniello, A.; Foschini, F.; Marciano, R.; Mozzillo, E.; Carratù, A.C.;
et al. Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. Cancers 2019, 11, 981.
https://doi.org/10.3390/cancers11070981
AMA Style
Napolitano F, Formisano L, Giardino A, Girelli R, Servetto A, Santaniello A, Foschini F, Marciano R, Mozzillo E, Carratù AC,
et al. Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. Cancers. 2019; 11(7):981.
https://doi.org/10.3390/cancers11070981
Chicago/Turabian Style
Napolitano, Fabiana, Luigi Formisano, Alessandro Giardino, Roberto Girelli, Alberto Servetto, Antonio Santaniello, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Anna Chiara Carratù,
and et al. 2019. "Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review" Cancers 11, no. 7: 981.
https://doi.org/10.3390/cancers11070981
APA Style
Napolitano, F., Formisano, L., Giardino, A., Girelli, R., Servetto, A., Santaniello, A., Foschini, F., Marciano, R., Mozzillo, E., Carratù, A. C., Cascetta, P., De Placido, P., De Placido, S., & Bianco, R.
(2019). Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. Cancers, 11(7), 981.
https://doi.org/10.3390/cancers11070981
